| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LogicBio Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 16 Nov 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924322036289-kahn-susan-2022-11-16 | LogicBio Therapeutics, Inc. | 16 Nov 2022 | 1 | $0 | 4 | Director | 17 Nov 2022, 20:02 |
| /report/000120919122038238-kahn-susan-2022-06-17 | LogicBio Therapeutics, Inc. | 17 Jun 2022 | 1 | $0 | 4 | Director | 21 Jun 2022, 08:10 |
| /report/000120919121071017-kahn-susan-2021-12-21 | LogicBio Therapeutics, Inc. | 21 Dec 2021 | 1 | $0 | 4 | Director | 23 Dec 2021, 08:14 |
| /report/000120919121071016-kahn-susan-2021-12-21 | LogicBio Therapeutics, Inc. | 21 Dec 2021 | 0 | $0 | 3 | Director | 23 Dec 2021, 08:11 |